• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对有更年期症状女性使用中药情况的批判性综述。

A critical review of traditional Chinese medicine use amongst women with menopausal symptoms.

作者信息

Peng W, Sibbritt D W, Hickman L, Kong X, Yang L, Adams J

机构信息

Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney , Sydney, NSW , Australia.

出版信息

Climacteric. 2014 Dec;17(6):635-44. doi: 10.3109/13697137.2014.904850. Epub 2014 Jul 9.

DOI:10.3109/13697137.2014.904850
PMID:24678630
Abstract

OBJECTIVES

To provide the first critical review of traditional Chinese medicine (TCM) use amongst symptomatic menopausal women, drawing upon work examining the perspectives of both TCM users and TCM practitioners.

METHODS

A search was conducted in three English-language databases (MEDLINE, CINAHL and AMED) and three Chinese-language databases (CNKI, VIP and CBM Disc) for 2002-2013 international peer-reviewed articles reporting empirical findings of TCM use in menopause.

RESULTS

A total of 25 journal articles reporting 22 studies were identified as meeting the review inclusion criteria. Chinese herbal medicine appears to be the most common therapy amongst symptomatic menopausal women, and vasomotor symptoms and emotional changes are the most frequent symptoms for which TCM is sought. However, evidence regarding the prevalence of TCM use and users' profile in menopause is limited. Existing studies are of varied methodological quality, often reporting low response rate, extensive recall bias and a lack of syndrome differentiation.

CONCLUSIONS

This review provides insights for practitioners and health policy-makers regarding TCM care to symptomatic menopausal women. More nationally representative studies are required to rigorously examine TCM use for the management of menopausal symptoms. Syndrome differentiation of menopausal women is an area which also warrants further attention.

摘要

目的

通过研究中医使用者和中医从业者的观点,首次对有症状的更年期女性使用中医的情况进行批判性综述。

方法

在三个英文数据库(MEDLINE、CINAHL和AMED)和三个中文数据库(CNKI、VIP和CBM Disc)中进行检索,查找2002年至2013年国际同行评审的文章,这些文章报告了中医在更年期使用情况的实证研究结果。

结果

共有25篇期刊文章报告了22项研究,这些研究被确定符合综述纳入标准。中药似乎是有症状的更年期女性中最常用的疗法,血管舒缩症状和情绪变化是寻求中医治疗的最常见症状。然而,关于更年期中医使用的患病率和使用者特征的证据有限。现有研究的方法学质量参差不齐,经常报告低应答率、广泛的回忆偏倚和缺乏辨证。

结论

本综述为从业者和卫生政策制定者提供了有关对有症状的更年期女性进行中医护理的见解。需要更多具有全国代表性的研究来严格检验中医用于管理更年期症状的情况。更年期女性的辨证也是一个值得进一步关注的领域。

相似文献

1
A critical review of traditional Chinese medicine use amongst women with menopausal symptoms.对有更年期症状女性使用中药情况的批判性综述。
Climacteric. 2014 Dec;17(6):635-44. doi: 10.3109/13697137.2014.904850. Epub 2014 Jul 9.
2
Effects of traditional Chinese medicine on symptom clusters during the menopausal transition.中药对绝经过渡期间症状群的影响。
Climacteric. 2015 Apr;18(2):142-56. doi: 10.3109/13697137.2014.937687. Epub 2014 Oct 18.
3
Critical Review of Data Evaluation in Teaching Clinics of Traditional Chinese Medicine Outside China: Implications for Education.中国境外中医教学诊所数据评估的批判性综述:对教育的启示
Explore (NY). 2016 May-Jun;12(3):188-95. doi: 10.1016/j.explore.2016.02.006. Epub 2016 Mar 2.
4
Critical review of complementary and alternative medicine use in menopause: focus on prevalence, motivation, decision-making, and communication.更年期补充和替代医学使用情况的批判性综述:聚焦于患病率、动机、决策制定及沟通。
Menopause. 2014 May;21(5):536-48. doi: 10.1097/GME.0b013e3182a46a3e.
5
Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan.台湾地区围绝经期妇女的中医药处方模式。
Climacteric. 2009 Dec;12(6):541-7. doi: 10.3109/13697130903060081.
6
The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries.亚洲国家的中医药治疗绝经期症状。
Climacteric. 2021 Feb;24(1):64-67. doi: 10.1080/13697137.2020.1832461. Epub 2020 Oct 23.
7
Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database.中草药治疗更年期综合征的处方模式:全国处方数据库分析。
J Ethnopharmacol. 2011 Oct 11;137(3):1261-6. doi: 10.1016/j.jep.2011.07.053. Epub 2011 Aug 2.
8
Erxian decoction, a Chinese herbal formula, for menopausal syndrome: An updated systematic review.二仙汤治疗围绝经期综合征的系统评价更新。
J Ethnopharmacol. 2019 Apr 24;234:8-20. doi: 10.1016/j.jep.2019.01.010. Epub 2019 Jan 15.
9
Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial.针灸和中药(知母 14)对绝经后妇女热潮红和生活质量的影响:一项四臂随机对照初步试验的结果。
Menopause. 2014 Jan;21(1):15-24. doi: 10.1097/GME.0b013e31829374e8.
10
The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.与激素替代疗法(HRT)和安慰剂相比,中草药(CHM)对更年期症状的影响。
Maturitas. 2007 Sep 20;58(1):83-90. doi: 10.1016/j.maturitas.2007.06.005. Epub 2007 Aug 8.

引用本文的文献

1
Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).在东亚女性中,fezolinetant 治疗与绝经相关的中度至重度血管舒缩症状的疗效和安全性:一项 3 期随机研究(MOONLIGHT I)。
J Int Med Res. 2024 May;52(5):3000605241247684. doi: 10.1177/03000605241247684.
2
An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.评价瑞戈非尼/雌二醇/醋酸炔诺酮酯治疗绝经前妇女子宫肌瘤相关重度月经过多。
Expert Opin Pharmacother. 2022 Mar;23(4):421-429. doi: 10.1080/14656566.2022.2030705. Epub 2022 Jan 24.
3
Astragalin, a Flavonoid from Morus alba (Mulberry) Increases Endogenous Estrogen and Progesterone by Inhibiting Ovarian Granulosa Cell Apoptosis in an Aged Rat Model of Menopause.
黄芪苷,一种来自桑树的黄酮类化合物,通过抑制老年绝经大鼠模型中卵巢颗粒细胞凋亡来增加内源性雌激素和孕酮。
Molecules. 2016 May 21;21(5):675. doi: 10.3390/molecules21050675.
4
Chinese herbal medicine for menopausal symptoms.用于缓解更年期症状的中草药
Cochrane Database Syst Rev. 2016 Mar 15;3(3):CD009023. doi: 10.1002/14651858.CD009023.pub2.